# The Use of a Non-absorbable Marker for the Evaluation of the Gastrointestinal Transit

> **NCT01780909** · NA · UNKNOWN · sponsor: **KU Leuven** · enrollment: 10 (estimated)

## Conditions studied

- Concentration-Time Profiles in Stomach & Intestine.

## Interventions

- **DRUG:** Paromomycin Sulfate Fasted State
- **DRUG:** Paromomycin Sulfate Fed State
- **DRUG:** Paromomycin Sulfate w/ domperidone
- **DRUG:** Paromomycin Sulfate w/ loperamide HCl

## Key facts

- **NCT ID:** NCT01780909
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2013-12
- **Final completion:** 2017-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2014-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01780909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01780909, "The Use of a Non-absorbable Marker for the Evaluation of the Gastrointestinal Transit". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01780909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*